XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Rental income $ 4,032,429 $ 4,639,726
Fees and other income 92,755 150,335
Total revenue 4,125,184 4,790,061
Costs and expenses:    
Rental operating costs 1,612,642 1,563,577
General and administrative 1,661,978 2,084,450
Depreciation and amortization 1,244,104 1,351,018
Impairment of goodwill and real estate assets 26,943 95,548
Total costs and expenses 4,545,667 5,094,593
Other income (expense):    
Interest and other income, net 5,149 4,646
Gain on sales of real estate, net 4,453,968 2,018,095
Net loss in Conduit Pharmaceuticals marketable securities (see footnote 9) (176,658) (3,861,233)
Income tax (expense) benefit 25,409 (79,565)
Total other income (expense), net 2,797,398 (3,433,263)
Net (loss) income 2,376,915 (3,737,795)
Less: Income attributable to noncontrolling interests (111,563) (1,503,868)
Net income (loss) attributable to Presidio Property Trust, Inc. stockholders 2,265,352 (5,241,663)
Less: Preferred Stock Series D dividends (579,575) (522,032)
Net income (loss) attributable to Presidio Property Trust, Inc. common stockholders $ 1,685,777 $ (5,763,695)
Net income (loss) per share attributable to Presidio Property Trust, Inc. common stockholders:    
Basic & Diluted (in dollars per share) $ 0.13 $ (0.47)
Weighted average number of common shares outstanding - basic & dilutive (in shares) 12,973,299 12,293,190
Mortgage Notes [Member]    
Other income (expense):    
Interest expense - mortgage notes $ (1,510,470) $ (1,515,206)